Key result
Pharmacotherapy in ACS patients showed 66% adherence to ACC/AHA guidelines, low generic prescribing, and an average of 10.19 drugs per patient.
Why the study?
ACS has a rising burden in India, where rational drug utilization and adherence to evidence-based guidelines are crucial to improve clinical outcomes and minimize complications. This study evaluated drug utilization patterns, guideline adherence, associated risk factors, and clinical outcomes in patients with ACS.
Observational (n=200)
No
In an Indian tertiary care cohort of 200 ACS patients, prescribing practices showed high polypharmacy (mean 10.19 drugs), low generic use (20%), and suboptimal ACC/AHA guideline adherence (66%), highlighting areas for clinical quality improvement.
Answers are grounded in this paper and cite their sources.
Supports targeted quality improvement for ACS prescribing; leaves open outcome links in broader prospective studies.
Introduction: Acute Coronary Syndrome (ACS) remains a major contributor to morbidity and mortality worldwide, with a rising burden in India. Rational drug utilization and adherence to evidence-based treatment guidelines play a crucial role in improving clinical outcomes and minimizing complications in ACS patients. This study aimed to evaluate drug utilization patterns, adherence to guidelines, associated risk factors, and clinical outcomes in patients with ACS. Materials & Methods: This prospective observational study was conducted over 6 months in the Cardiac Care Unit of Basaveshwara Medical College and Hospital, Chitradurga. A total of 200 patients diagnosed with ACS were included. Data on demographics, comorbidities, risk factors, prescribed medications, and outcomes were collected from patient records. Drug utilization was assessed using WHO core prescribing indicators. Clinical outcomes evaluated were length of hospital stay, complications, readmissions, and major adverse cardiovascular events (MACE). Results: ST-elevation myocardial infarction was the most common presentation (63%), followed by non-ST-elevation myocardial infarction (28.5%) and unstable angina (8.5%). Polypharmacy was evident, with an average of 10.19 drugs prescribed per patient. Antiplatelets, statins, anticoagulants, and anti-anginal agents were the most frequently prescribed drug classes. Generic prescribing was low (20%), and 74.2% of drugs were from the essential drug list. Adherence to ACC/AHA guidelines was observed in 66% of prescriptions. Most patients had a hospital stay of 2-4 days, with generally favourable clinical outcomes and low rates of readmission and MACE. Discussion: The findings show frequent polypharmacy, low generic prescribing, and guideline adherence in about two-thirds of prescriptions, indicating scope for improvement in prescribing practices, despite generally favourable clinical outcomes. Conclusion: The study highlights the need to strengthen guideline-based prescribing practices, promote the use of generic drugs, and enhance monitoring strategies to optimise the management of ACS patients.
No takes yet. Share an insight, caveat, or question.
R et al. (2026) conducted an observational in Acute Coronary Syndrome (ACS) (n=200). Prescribed pharmacotherapy for Acute Coronary Syndrome (antiplatelets, statins, anticoagulants, and anti-anginal agents) was evaluated on Drug utilization patterns (WHO core prescribing indicators, ACC/AHA guideline adherence) and clinical outcomes (length of hospital stay, complications, readmissions, and MACE). Pharmacotherapy in ACS patients showed 66% adherence to ACC/AHA guidelines, low generic prescribing, and an average of 10.19 drugs per patient.
Synapse has enriched 10 related papers. Consider them for comparative context: